Kui Wang
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 12
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 12
- Genomics, phytochemicals, and oxidative stress 10
- RNA modifications and cancer 10
- Neurology top 5%
- Geriatrics and Gerontology top 2%
- Pharmacology top 1%
-
- Autophagy in Disease and Therapy 15
-
- Hepatocellular Carcinoma Treatment and Prognosis 13
-
- Endoplasmic Reticulum Stress and Disease 11
-
- Cancer Cells and Metastasis 10
- Co-authors
- Canhua HuangEdouard C. NiceYunlong LeiYuquan WeiTian‐Lan ZhangHai‐Ning ChenLan YuanJingwen Jiang
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Kui Wang
218 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 171
- Cancer Research 946
- Molecular Biology 3.6k
- Neurology 289
- Geriatrics and Gerontology 136
- Pharmacology 299
Countries citing papers authored by Kui Wang
This map shows the geographic impact of Kui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Wang more than expected).
Fields of papers citing papers by Kui Wang
This network shows the impact of papers produced by Kui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Wang. The network helps show where Kui Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 23 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 18 | |
| 14 | 2019 | 32 | |
| 15 | 2019 | 11 | |
| 16 | 2018 | 27 | |
| 17 | 2016 | 93 | |
| 18 | 2016 | 191 | |
| 19 | 2013 | 85 | |
| 20 | 2010 | 72 |
About Kui Wang
Kui Wang is a scholar working on Hepatology, Molecular Biology, Developmental Neuroscience, Cancer Research and Geriatrics and Gerontology, having authored 226 papers that have together received 7.3k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer, Hypoxia, and Metabolism (12 papers), Epigenetics and DNA Methylation (12 papers), Endoplasmic Reticulum Stress and Disease (11 papers), Genomics, phytochemicals, and oxidative stress (10 papers), RNA modifications and cancer (10 papers) and Cancer Cells and Metastasis (10 papers). The work is most often cited by research in Cancer Research (946 citations), Molecular Biology (3.6k citations), Neurology (289 citations), Geriatrics and Gerontology (136 citations) and Pharmacology (299 citations). Kui Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Canhua Huang, Edouard C. Nice, Yunlong Lei, Yuquan Wei, Tian‐Lan Zhang, Hai‐Ning Chen, Lan Yuan, Jingwen Jiang, Jian Huang and Lukasz Kurgan. Their work appears in journals such as Autophagy, Cancer Research, BioMetals, Journal of Cellular Biochemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.